You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華森製藥(002907.SZ)收漲4.89% 產成品有清肺排毒湯組方中的中藥材
格隆匯 02-18 15:04
格隆匯2月18日丨華森製藥(002907.SZ)今日收漲4.89%報19.08元,成交1.49億元,最新總市值76.62億元。公司在互動平台表示,公司擁有中藥提取及中藥飲片生產線,清肺排毒湯21味中藥組成中,相關產成品有清肺排毒湯組方中的中藥材,其組方中的“射干”、“白朮”分別為公司獨家中成藥“甘桔冰梅片”和“都樑軟膠囊”的中藥原材料之一。關於中藥材的使用,公司均用於自有產品的生產,目前尚未對外銷售。 針對本次疫情,公司擁有3個產品可用於疫情防控:一是公司獨家中成藥品種甘桔冰梅片,二是公司產品鹽酸戊乙奎醚注射液(1ml:1mg),三是公司產品注射用甘草酸二銨有望在抗擊新冠肺炎中產生良好臨牀效果。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account